Portfolio Holdings Detail for ISIN IE00B6R52259
| Stock Name / Fund | iShares MSCI ACWI UCITS ETF |
| Issuer | Blackrock |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | IUSQ(EUR) F |
| ETF Ticker | ISAC.LS(USD) CXE |
| ETF Ticker | IUSQ.DE(EUR) CXE |
| ETF Ticker | SSAC.AS(EUR) CXE |
| ETF Ticker | SSAC.LS(GBX) CXE |
| ETF Ticker | SSACz(USD) CXE |
| ETF Ticker | SSAC(EUR) Euronext Amsterdam |
| ETF Ticker | ISAC(EUR) ETF Plus |
Holdings detail for UTHR
| Stock Name | United Therapeutics Corporation |
| Ticker | UTHR(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US91307C1027 |
| LEI | 5299005C4HZL4UWROC14 |
Show aggregate UTHR holdings
News associated with UTHR
- United Therapeutics (NASDAQ:UTHR) Earns “Buy” Rating from HC Wainwright
- United Therapeutics (NASDAQ:UTHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $425.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price suggests a potential upside of 44.06% from the stock’s previous close. HC Wainwright […] - 2025-05-07 05:22:52
- United Therapeutics (NASDAQ:UTHR) Cut to Buy at StockNews.com
- StockNews.com lowered shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Several other brokerages also recently issued reports on UTHR. Morgan Stanley upped their price target on United Therapeutics from $346.00 to $348.00 and gave the stock an […] - 2025-05-05 05:28:51
- The Top 3 Stock Picks at the World’s Greatest Hedge Fund
- A reclusive firm is often considered the world’s most successful hedge fund. That company is Renaissance Technologies. This company’s prominence is largely due to its Medallion Fund, which generated an annualized return of 39% after fees from 1988 to 2021. Its founder, Jim Simon - 2025-05-02 11:15:00
- United Therapeutics (NASDAQ:UTHR) Shares Gap Up After Better-Than-Expected Earnings
- Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $300.76, but opened at $317.10. United Therapeutics shares last traded at $298.77, with a volume of 87,993 shares changing hands. The biotechnology […] - 2025-05-02 05:10:54
- United Therapeutics (NASDAQ:UTHR) Stock Rating Upgraded by Bank of America
- United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by investment analysts at Bank of America from an “underperform” rating to a “neutral” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm currently has a $314.00 price target on the biotechnology company’s stock. Bank of America‘s target price points to […] - 2025-04-23 05:10:56
- Raymond James Financial Inc. Takes Position in United Therapeutics Co. (NASDAQ:UTHR)
- Raymond James Financial Inc. purchased a new position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,744 shares of the biotechnology company’s stock, valued at approximately $18,257,000. A number of other […] - 2025-04-21 07:40:49
- Envestnet Asset Management Inc. Grows Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
- Envestnet Asset Management Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,880 shares of the biotechnology company’s stock after buying an additional 2,889 shares during the quarter. Envestnet Asset […] - 2025-04-15 08:14:52
- Cerity Partners LLC Buys 2,702 Shares of United Therapeutics Co. (NASDAQ:UTHR)
- Cerity Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,588 shares of the biotechnology company’s stock after purchasing an additional 2,702 shares during the quarter. Cerity […] - 2025-04-14 10:32:44
- Federated Hermes Inc. Increases Position in United Therapeutics Co. (NASDAQ:UTHR)
- Federated Hermes Inc. lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,078 shares of the biotechnology company’s stock after buying an additional 305 shares during the quarter. Federated Hermes […] - 2025-04-14 09:54:56
- Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $3,367,980.00 in Stock
- United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 11,000 shares of the stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $306.18, for a total value of $3,367,980.00. Following the sale, the executive vice president now owns 36,781 shares in the company, […] - 2025-04-10 08:12:55
- Raymond Dwek Sells 4,000 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock
- United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) Director Raymond Dwek sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $284.55, for a total value of $1,138,200.00. Following the completion of the transaction, the director now owns 1,750 shares […] - 2025-04-10 08:12:54
- United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of “Moderate Buy” by Brokerages
- Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a […] - 2025-04-09 06:08:53
- Korea Investment CORP Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
- Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares of the biotechnology company’s stock after buying an additional 2,300 shares during the quarter. Korea Investment CORP’s holdings in United Therapeutics were worth $13,863,000 at the […] - 2025-03-31 10:40:53
- United Therapeutics Co. (NASDAQ:UTHR) Stock Position Raised by Envestnet Portfolio Solutions Inc.
- Envestnet Portfolio Solutions Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,082 shares of the biotechnology company’s stock after acquiring an additional 81 shares during the period. Envestnet […] - 2025-03-27 09:14:51
- Commonwealth Equity Services LLC Acquires 301 Shares of United Therapeutics Co. (NASDAQ:UTHR)
- Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,526 shares of the biotechnology company’s stock after buying an additional 301 shares during the quarter. […] - 2025-03-26 08:35:07
- M&T Bank Corp Has $1.21 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
- M&T Bank Corp increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 9.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,429 shares of the biotechnology company’s stock after buying an additional 294 shares […] - 2025-03-11 09:34:53
- IFP Advisors Inc Trims Holdings in United Therapeutics Co. (NASDAQ:UTHR)
- IFP Advisors Inc lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 855 shares of the biotechnology company’s stock after selling 194 shares during the period. […] - 2025-03-03 09:00:52
- Global Retirement Partners LLC Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)
- Global Retirement Partners LLC raised its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 38.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 596 shares of the biotechnology company’s stock after purchasing an additional 164 shares during the period. Global Retirement Partners LLC’s holdings in United Therapeutics were worth $210,000 as […] - 2025-02-26 09:54:53
- Blue Trust Inc. Cuts Position in United Therapeutics Co. (NASDAQ:UTHR)
- Blue Trust Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,149 shares of the biotechnology company’s stock after selling 256 shares during the quarter. Blue Trust Inc.’s […] - 2025-02-18 11:06:55
- Chevy Chase Trust Holdings LLC Reduces Stake in United Therapeutics Co. (NASDAQ:UTHR)
- Chevy Chase Trust Holdings LLC reduced its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,726 shares of the biotechnology company’s stock after selling 323 shares during the period. […] - 2025-02-18 08:42:54
- Bleakley Financial Group LLC Purchases 389 Shares of United Therapeutics Co. (NASDAQ:UTHR)
- Bleakley Financial Group LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 58.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,059 shares of the biotechnology company’s stock after purchasing an additional 389 shares during the […] - 2025-02-11 08:56:58
- Notable ETF Outflow Detected - XBI, NBIX, ALNY, UTHR
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $76.4 million dollar outflow -- that's a 1.2% decrease week over week ( - 2025-02-05 16:06:35
- Blue Trust Inc. Raises Position in United Therapeutics Co. (NASDAQ:UTHR)
- Blue Trust Inc. lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 24.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,745 shares of the biotechnology company’s stock after buying an additional 340 shares during […] - 2025-01-31 08:51:09
iShares MSCI ACWI UCITS ETF UTHR holdings
| Date | Number of UTHR Shares Held | Base Market Value of UTHR Shares | Local Market Value of UTHR Shares | Change in UTHR Shares Held | Change in UTHR Base Value | Current Price per UTHR Share Held | Previous Price per UTHR Share Held |
|---|
| 2025-05-08 (Thursday) | 13,221 | USD 4,072,068 | USD 4,072,068 | | | | |
| 2025-05-07 (Wednesday) | 13,186 | USD 4,047,047 | USD 4,047,047 | | | | |
| 2025-05-06 (Tuesday) | 13,074 | USD 3,857,091 | USD 3,857,091 | 0 | USD -48,113 | USD 295.02 | USD 298.7 |
| 2025-05-05 (Monday) | 13,074 | USD 3,905,204 | USD 3,905,204 | 0 | USD 53,604 | USD 298.7 | USD 294.6 |
| 2025-05-02 (Friday) | 13,074 | USD 3,851,600 | USD 3,851,600 | 0 | USD 9,805 | USD 294.6 | USD 293.85 |
| 2025-05-01 (Thursday) | 13,074 | USD 3,841,795 | USD 3,841,795 | 0 | USD -120,804 | USD 293.85 | USD 303.09 |
| 2025-04-30 (Wednesday) | 13,074 | USD 3,962,599 | USD 3,962,599 | 21 | USD 36,779 | USD 303.09 | USD 300.76 |
| 2025-04-29 (Tuesday) | 13,053 | USD 3,925,820 | USD 3,925,820 | 0 | USD 48,557 | USD 300.76 | USD 297.04 |
| 2025-04-28 (Monday) | 13,053 | USD 3,877,263 | USD 3,877,263 | 0 | USD 73,880 | USD 297.04 | USD 291.38 |
| 2025-04-25 (Friday) | 13,053 | USD 3,803,383 | USD 3,803,383 | 0 | USD -65,787 | USD 291.38 | USD 296.42 |
| 2025-04-24 (Thursday) | 13,053 | USD 3,869,170 | USD 3,869,170 | 7 | USD 40,691 | USD 296.42 | USD 293.46 |
| 2025-04-23 (Wednesday) | 13,046 | USD 3,828,479 | USD 3,828,479 | 56 | USD 24,747 | USD 293.46 | USD 292.82 |
| 2025-04-22 (Tuesday) | 12,990 | USD 3,803,732 | USD 3,803,732 | 0 | USD 111,324 | USD 292.82 | USD 284.25 |
| 2025-04-21 (Monday) | 12,990 | USD 3,692,408 | USD 3,692,408 | 0 | USD -6,235 | USD 284.25 | USD 284.73 |
| 2025-04-18 (Friday) | 12,990 | USD 3,698,643 | USD 3,698,643 | 0 | USD 0 | USD 284.73 | USD 284.73 |
| 2025-04-17 (Thursday) | 12,990 | USD 3,698,643 | USD 3,698,643 | 28 | USD 2,010 | USD 284.73 | USD 285.19 |
| 2025-04-16 (Wednesday) | 12,962 | USD 3,696,633 | USD 3,696,633 | 14 | USD 8,784 | USD 285.19 | USD 284.82 |
| 2025-04-15 (Tuesday) | 12,948 | USD 3,687,849 | USD 3,687,849 | 14 | USD 10,583 | USD 284.82 | USD 284.31 |
| 2025-04-14 (Monday) | 12,934 | USD 3,677,266 | USD 3,677,266 | 42 | USD 52,551 | USD 284.31 | USD 281.16 |
| 2025-04-11 (Friday) | 12,892 | USD 3,624,715 | USD 3,624,715 | 112 | USD 60,501 | USD 281.16 | USD 278.89 |
| 2025-04-10 (Thursday) | 12,780 | USD 3,564,214 | USD 3,564,214 | 63 | USD -159,069 | USD 278.89 | USD 292.78 |
| 2025-04-09 (Wednesday) | 12,717 | USD 3,723,283 | USD 3,723,283 | 35 | USD 176,254 | USD 292.78 | USD 279.69 |
| 2025-04-08 (Tuesday) | 12,682 | USD 3,547,029 | USD 3,547,029 | 35 | USD -142,354 | USD 279.69 | USD 291.72 |
| 2025-04-07 (Monday) | 12,647 | USD 3,689,383 | USD 3,689,383 | 28 | USD -1,170 | USD 291.72 | USD 292.46 |
| 2025-04-04 (Friday) | 12,619 | USD 3,690,553 | USD 3,690,553 | 35 | USD -238,927 | USD 292.46 | USD 312.26 |
| 2025-04-02 (Wednesday) | 12,584 | USD 3,929,480 | USD 3,929,480 | 28 | USD 76,295 | USD 312.26 | USD 306.88 |
| 2025-04-01 (Tuesday) | 12,556 | USD 3,853,185 | USD 3,853,185 | 0 | USD -17,453 | USD 306.88 | USD 308.27 |
| 2025-03-31 (Monday) | 12,556 | USD 3,870,638 | USD 3,870,638 | 0 | USD 16,323 | USD 308.27 | USD 306.97 |
| 2025-03-28 (Friday) | 12,556 | USD 3,854,315 | USD 3,854,315 | 28 | USD -4,560 | USD 306.97 | USD 308.02 |
| 2025-03-27 (Thursday) | 12,528 | USD 3,858,875 | USD 3,858,875 | 0 | USD -35,078 | USD 308.02 | USD 310.82 |
| 2025-03-26 (Wednesday) | 12,528 | USD 3,893,953 | USD 3,893,953 | 0 | USD -74,040 | USD 310.82 | USD 316.73 |
| 2025-03-25 (Tuesday) | 12,528 | USD 3,967,993 | USD 3,967,993 | 0 | USD -39,213 | USD 316.73 | USD 319.86 |
| 2025-03-24 (Monday) | 12,528 | USD 4,007,206 | USD 4,007,206 | 14 | USD 90,449 | USD 319.86 | USD 312.99 |
| 2025-03-21 (Friday) | 12,514 | USD 3,916,757 | USD 3,916,757 | 0 | USD -7,633 | USD 312.99 | USD 313.6 |
| 2025-03-20 (Thursday) | 12,514 | USD 3,924,390 | USD 3,924,390 | 0 | USD -65,699 | USD 313.6 | USD 318.85 |
| 2025-03-19 (Wednesday) | 12,514 | USD 3,990,089 | USD 3,990,089 | 0 | USD 59,191 | USD 318.85 | USD 314.12 |
| 2025-03-18 (Tuesday) | 12,514 | USD 3,930,898 | USD 3,930,898 | 21 | USD -103,591 | USD 314.12 | USD 322.94 |
| 2025-03-17 (Monday) | 12,493 | USD 4,034,489 | USD 4,034,489 | 35 | USD 206,893 | USD 322.94 | USD 307.24 |
| 2025-03-14 (Friday) | 12,458 | USD 3,827,596 | USD 3,827,596 | 28 | USD 31,598 | USD 307.24 | USD 305.39 |
| 2025-03-13 (Thursday) | 12,430 | USD 3,795,998 | USD 3,795,998 | 63 | USD -1,784 | USD 305.39 | USD 307.09 |
| 2025-03-12 (Wednesday) | 12,367 | USD 3,797,782 | USD 3,797,782 | 0 | USD 33,020 | USD 307.09 | USD 304.42 |
| 2025-03-11 (Tuesday) | 12,367 | USD 3,764,762 | USD 3,764,762 | 0 | USD -166,336 | USD 304.42 | USD 317.87 |
| 2025-03-10 (Monday) | 12,367 | USD 3,931,098 | USD 3,931,098 | 21 | USD 30,873 | USD 317.87 | USD 315.91 |
| 2025-03-07 (Friday) | 12,346 | USD 3,900,225 | USD 3,900,225 | 0 | USD 60,866 | USD 315.91 | USD 310.98 |
| 2025-03-05 (Wednesday) | 12,346 | USD 3,839,359 | USD 3,839,359 | 0 | USD 29,507 | USD 310.98 | USD 308.59 |
| 2025-03-04 (Tuesday) | 12,346 | USD 3,809,852 | USD 3,809,852 | 28 | USD -9,098 | USD 308.59 | USD 310.03 |
| 2025-03-03 (Monday) | 12,318 | USD 3,818,950 | USD 3,818,950 | 0 | USD -123,426 | USD 310.03 | USD 320.05 |
| 2025-02-28 (Friday) | 12,318 | USD 3,942,376 | USD 3,942,376 | 0 | USD -43,975 | USD 320.05 | USD 323.62 |
| 2025-02-27 (Thursday) | 12,318 | USD 3,986,351 | USD 3,986,351 | 0 | USD 58,264 | USD 323.62 | USD 318.89 |
| 2025-02-26 (Wednesday) | 12,318 | USD 3,928,087 | USD 3,928,087 | | | | |
| 2024-11-12 (Tuesday) | 11,744 | USD 4,707,817 | USD 4,707,817 | 0 | USD 5,050 | USD 400.87 | USD 400.44 |
| 2024-11-11 (Monday) | 11,744 | USD 4,702,767 | USD 4,702,767 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of UTHR by Blackrock for IE00B6R52259
Show aggregate share trades of UTHR| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-04-30 | BUY | 21 | | | 303.090* | | 304.67 |
| 2025-04-24 | BUY | 7 | | | 296.420* | | 305.52 |
| 2025-04-23 | BUY | 56 | | | 293.460* | | 305.84 |
| 2025-04-17 | BUY | 28 | | | 284.730* | | 308.10 |
| 2025-04-16 | BUY | 14 | | | 285.190* | | 308.79 |
| 2025-04-15 | BUY | 14 | | | 284.820* | | 309.54 |
| 2025-04-14 | BUY | 42 | | | 284.310* | | 310.36 |
| 2025-04-11 | BUY | 112 | | | 281.160* | | 311.33 |
| 2025-04-10 | BUY | 63 | | | 278.890* | | 312.45 |
| 2025-04-09 | BUY | 35 | | | 292.780* | | 313.15 |
| 2025-04-08 | BUY | 35 | | | 279.690* | | 314.39 |
| 2025-04-07 | BUY | 28 | | | 291.720* | | 315.26 |
| 2025-04-04 | BUY | 35 | | | 292.460* | | 316.17 |
| 2025-04-02 | BUY | 28 | | | 312.260* | | 316.34 |
| 2025-03-28 | BUY | 28 | | | 306.970* | | 317.62 |
| 2025-03-24 | BUY | 14 | | | 319.860* | | 318.50 |
| 2025-03-18 | BUY | 21 | | | 314.120* | | 319.62 |
| 2025-03-17 | BUY | 35 | | | 322.940* | | 319.34 |
| 2025-03-14 | BUY | 28 | | | 307.240* | | 320.44 |
| 2025-03-13 | BUY | 63 | | | 305.390* | | 321.94 |
| 2025-03-10 | BUY | 21 | | | 317.870* | | 327.15 |
| 2025-03-04 | BUY | 28 | | | 308.590* | | 338.64 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of UTHR
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-05-09 | 93,732 | 2,043 | 142,962 | 65.6% |
| 2025-05-08 | 141,857 | 4,342 | 258,916 | 54.8% |
| 2025-05-07 | 134,785 | 316 | 179,122 | 75.2% |
| 2025-05-06 | 81,208 | 963 | 121,260 | 67.0% |
| 2025-05-05 | 78,415 | 322 | 128,882 | 60.8% |
| 2025-05-02 | 210,399 | 705 | 271,866 | 77.4% |
| 2025-05-01 | 124,118 | 8,633 | 196,039 | 63.3% |
| 2025-04-30 | 285,781 | 155 | 347,339 | 82.3% |
| 2025-04-29 | 154,596 | 477 | 218,202 | 70.8% |
| 2025-04-28 | 128,287 | 195 | 148,605 | 86.3% |
| 2025-04-25 | 82,074 | 69 | 105,749 | 77.6% |
| 2025-04-24 | 54,140 | 551 | 72,533 | 74.6% |
| 2025-04-23 | 54,712 | 710 | 75,899 | 72.1% |
| 2025-04-22 | 106,381 | 108 | 147,398 | 72.2% |
| 2025-04-21 | 97,968 | 288 | 131,097 | 74.7% |
| 2025-04-17 | 76,347 | 5,753 | 100,654 | 75.9% |
| 2025-04-16 | 100,908 | 441 | 119,070 | 84.7% |
| 2025-04-15 | 172,155 | 368 | 223,671 | 77.0% |
| 2025-04-14 | 65,848 | 206 | 133,861 | 49.2% |
| 2025-04-11 | 214,630 | 62 | 286,542 | 74.9% |
| 2025-04-10 | 113,256 | 201 | 219,439 | 51.6% |
| 2025-04-09 | 148,894 | 215 | 236,169 | 63.0% |
| 2025-04-08 | 170,352 | 99 | 242,720 | 70.2% |
| 2025-04-07 | 138,641 | 552 | 226,794 | 61.1% |
| 2025-04-04 | 140,921 | 289 | 250,242 | 56.3% |
| 2025-04-03 | 122,554 | 2,034 | 179,949 | 68.1% |
| 2025-04-02 | 84,226 | 120 | 160,167 | 52.6% |
| 2025-04-01 | 97,627 | 152 | 160,320 | 60.9% |
| 2025-03-31 | 120,162 | 56 | 207,238 | 58.0% |
| 2025-03-28 | 49,651 | 32 | 78,273 | 63.4% |
| 2025-03-27 | 79,854 | 40 | 122,176 | 65.4% |
| 2025-03-26 | 80,918 | 0 | 103,812 | 77.9% |
| 2025-03-25 | 66,033 | 24 | 116,460 | 56.7% |
| 2025-03-24 | 93,297 | 2,224 | 149,804 | 62.3% |
| 2025-03-21 | 77,622 | 0 | 109,375 | 71.0% |
| 2025-03-20 | 57,632 | 35 | 113,734 | 50.7% |
| 2025-03-19 | 66,677 | 1,715 | 160,035 | 41.7% |
| 2025-03-18 | 114,308 | 84 | 161,831 | 70.6% |
| 2025-03-17 | 139,624 | 0 | 179,773 | 77.7% |
| 2025-03-14 | 58,110 | 6 | 129,519 | 44.9% |
| 2025-03-13 | 102,993 | 19 | 193,829 | 53.1% |
| 2025-03-12 | 101,833 | 46 | 187,370 | 54.3% |
| 2025-03-11 | 141,445 | 129 | 220,644 | 64.1% |
| 2025-03-10 | 105,881 | 49 | 150,716 | 70.3% |
| 2025-03-07 | 186,879 | 133 | 250,342 | 74.6% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.